Your browser doesn't support javascript.
loading
Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study.
Chambers, Christina D; Johnson, Diana L; Xu, Ronghui; Luo, Yunjun; Lopez-Jimenez, Janina; Adam, Margaret P; Braddock, Stephen R; Robinson, Luther K; Vaux, Keith; Lyons Jones, Kenneth.
Affiliation
  • Chambers CD; Department of Pediatrics, University of California San Diego, La Jolla, CA, United States of America.
  • Johnson DL; Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, United States of America.
  • Xu R; Department of Pediatrics, University of California San Diego, La Jolla, CA, United States of America.
  • Luo Y; Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, United States of America.
  • Lopez-Jimenez J; Department of Mathematics, University of California San Diego, La Jolla, CA, United States of America.
  • Adam MP; Department of Pediatrics, University of California San Diego, La Jolla, CA, United States of America.
  • Braddock SR; Department of Pediatrics, University of California San Diego, La Jolla, CA, United States of America.
  • Robinson LK; Department of Pediatrics, University of Washington, Seattle, WA, United States of America.
  • Vaux K; Deparment of Pediatrics, Saint Louis University, St. Louis, MO, United States of America.
  • Lyons Jones K; Department of Pediatrics, State University of New York at Buffalo, Buffalo, NY, United States of America.
PLoS One ; 14(10): e0223603, 2019.
Article in En | MEDLINE | ID: mdl-31626646

Full text: 1 Database: MEDLINE Main subject: Pregnancy Outcome / Maternal Exposure / Antirheumatic Agents / Adalimumab Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged / Pregnancy Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2019 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Pregnancy Outcome / Maternal Exposure / Antirheumatic Agents / Adalimumab Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged / Pregnancy Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2019 Type: Article Affiliation country: United States